Erlotinib: A Viewpoint by Natasha B. Leighl

ISSN： 1175-6357

Source： American Journal of Cancer, Vol.4, Iss.4, 2005-01, pp. : 253-254

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Erlotinib in Advanced Pancreatic Cancer: A Viewpoint by Andrew H. Ko

By Ko Andrew H.

American Journal of Cancer, Vol. 5, Iss. 1, 2006-01 ,pp. : 41-42

Adis International

Access to resources Recommend Favorite

Erlotinib

By Robinson Dean M. Keating Gillian M. Perry Caroline M.

American Journal of Cancer, Vol. 4, Iss. 4, 2005-01 ,pp. : 247-252

Adis International

Access to resources Recommend Favorite

Erlotinib: In Advanced Pancreatic Cancer

By Simpson Dene Scott Lesley J. Noble Stuart

American Journal of Cancer, Vol. 5, Iss. 1, 2006-01 ,pp. : 35-40

Adis International

Access to resources Recommend Favorite

Treatment of multiple keratoacanthomas with erlotinib

By Reid David Guitart Joan Agulnik Mark Lacouture Mario

International Journal of Clinical Oncology, Vol. 15, Iss. 4, 2010-08 ,pp. : 413-415

Springer Publishing Company

Access to resources Recommend Favorite

Erlotinib in Glioblastoma - Lost in Translation?

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 11, Iss. 8, 2011-01 ,pp. : 748-755

Bentham Science Publishers

Access to resources Recommend Favorite